Ratings Align Technology, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 14/09/2024 am IST			5-day change	1st Jan Change
243.73 ^USD	+6.50%		+7.60%	-11.05%

10/09	Transcript : Align Technology, Inc. Presents at Baird's 2024 Global Healthcare Conference, Sep-10-2024 09:05 AM
04/09	Align Technology Announces New Regional Leadership Roles	CI

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Thanks to a sound financial situation, the firm has significant leeway for investment.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.

With an expected P/E ratio at 36.3 and 28.02 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company's enterprise value to sales, at 3.96 times its current sales, is high.
The company appears highly valued given the size of its balance sheet.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Source: Surperformance

Source: Refinitiv

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Fundamentals	Composite Valuation	Composite Momentum	Capi. ($)
	ALIGN TECHNOLOGY, INC.				1.71TCr
	ABBOTT LABORATORIES				20TCr
	MEDTRONIC PLC				12TCr
	BECTON, DICKINSON AND COMPANY				6.81TCr
	HOYA CORPORATION				4.73TCr
	CENCORA, INC.				4.66TCr
	METTLER-TOLEDO INTERNATIONAL, INC.				2.91TCr
	DEXCOM, INC.				2.76TCr
	TERUMO CORPORATION				2.72TCr
	STERIS PLC				2.43TCr
	Average				6.06TCr
	Weighted average by Cap.